MHRA

The Medicines and Healthcare products Regulatory Agency is the UK regulator responsible for approving and monitoring medicines, medical devices, and advanced therapies including those that use artificial intelligence. For organizations developing AI systems in healthcare or deploying them in clinical settings, MHRA approval and compliance requirements directly affect product timelines and market access in the UK and often influence international standards. MHRA publishes guidance on AI assurance, quality standards, and real-world performance monitoring that enterprise governance teams must incorporate into product development and post-launch oversight.

1 item

StandardsUK2026-10-06

UK Accepts All 44 NHS AI Commission Recommendations, Sets December 2026 Deadline

The UK government has accepted all 44 recommendations from the National Commission into the Regulation of AI in Healthcare. The commitment replaces one-time device approval with a lifecycle-based regulatory model for AI-enabled medical devices. Draft MHRA guidance on AI device change management is due December 2026, with a full implementation roadmap expected by Spring 2027.

MHRA NHS medical AI regulation post-market surveillance lifecycle governance UK regulatory sandbox medtech compliance